Ajuts a la recerca

EFSD and Novo Nordisk A/S Partnership for Diabetes Research in Europe

Organisme

The EFSD/Novo Nordisk Partnership for Diabetes Research in Europe Programme will accept applications from all fields of diabetes research and including both basic and clinical research.

Objecte

The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 35,000 employees in 75 countries, and markets its products in more than 180 countries.

Descripció

Programme and Research Focus

To achieve the goals and objectives of this Programme, EFSD and Novo Nordisk invite applications by issuing this “Request for Applications” (RFA).

The EFSD/Novo Nordisk Partnership for Diabetes Research in Europe Programme will accept applications from all fields of diabetes research and including both basic and clinical research.

Mechanisms of Support and Review

Research will be supported through the award of grants of up to Euro 100,000 for basic research projects and Euro 400,000 for clinical research projects.The definition of clinical research is a study performed in human individuals and where there is a focus on a clinically relevant and diabetes-related outcome.

The duration of each award will depend upon the needs of the project and as justified in the application. EFSD may, at the suggestion of the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.

Applications with a funding requirement larger than that specified above may be considered; in this case, the total funding requirement should be indicated and justified in the budget section of the application. According to the duration and timetable of the project, funds will be made annually.

Applications for an EFSD/Novo Nordisk grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be normally employed at a non-profit institution and the study must be performed at their place of work.

Applications will be subject to a scientific review by a specialised and independent ad hoc committee. Funding will require approval by a Programme Board convened for this purpose, and will be awarded by May 2014.

Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserve the right to request revision to applications in accordance with the recommendations of the Review Committee.

Research Grant Applications

Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review.

The deadlines for receipt of research grant applications for funding is 1 February 2014.

All budgets are to be prepared in Euro. For countries in which the Euro is not the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under “Budget Justification”.
 

Termini oficial

Deadline for submission of applications: 1 February 2014

Termini IISPV

Declaration of interest: IISPV's deadline: January 20th, 2014(europa@iispv.cat)

Full proposal: IISPV's deadline: January 27th, 2014

Pujar